Mayfield leads $23 mln financing of Mammoth Biosciences
San Francisco-based Mammoth Biosciences, which develops CRISPR-based disease detection platform, announced it has raised $23 million in Series A funding. Mayfield led the round, which included participation from NFX and 8VC. The company, which was founded in 2017 and came out of stealth mode earlier this year, previously raised seed funding from NFX.
1 August 2018•1 min read
